Skip to main content
John Ringman, MD, Neurology, Los Angeles, CA, Keck Hospital of USC

JohnMatthewRingmanMD

Neurology Los Angeles, CA

Professor of Neurology at the Memory and Aging Center at the Keck School of Medicine of USC

Dr. Ringman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ringman's full profile

Already have an account?

  • Office

    USC Healthcare Center II
    1520 San Pablo St
    Los Angeles, CA 90033
    Phone+1 323-442-5710
    Fax+1 323-442-5736
  • Is this information wrong?

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineResidency, Neurology, 1994 - 1997
  • Baylor College of Medicine
    Baylor College of MedicineInternship, Internal Medicine, 1993 - 1994
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1997 - 2025
  • American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Stunning Diagnostic Accuracy from a Plasma Protein Panel?
    Stunning Diagnostic Accuracy from a Plasma Protein Panel?June 11th, 2021
  • What Is My Risk for Alzheimer’s Disease?
    What Is My Risk for Alzheimer’s Disease?March 1st, 2018
  • Supplements Are a $30 Billion Racket—Here’s What Experts Actually Recommend
    Supplements Are a $30 Billion Racket—Here’s What Experts Actually RecommendFebruary 20th, 2018
  • Join now to see all

Grant Support

  • Clinical CoreNational Institute On Aging2010–2012
  • UCLA Alzeheimer'S Disease Research CenterNational Institute On Aging2010
  • Behavioral And Neurochemical Correlates Of Presenilin-1 Mutation StatusNational Center For Research Resources2006–2010
  • A Phase II, Double-Blind, Placebo-Controlled Study Of The Safety And TolerabilNational Center For Research Resources2005–2009
  • Clinical Trial: -KNational Center For Research Resources2008
  • Evaluation Of The Safety, Tolerability And Impact On Biomarkers Of Anti-OxidaNational Center For Research Resources2007–2008
  • #Name?National Center For Research Resources2007
  • High Dose Supplements To Reduce Homocysteine And Slow The Rate Of CognitiveNational Center For Research Resources2005–2007
  • Treatment Of Agitation/Psychosis In Dementia/Parkingsonism (Tap/Dap)National Center For Research Resources2005–2006
  • KNational Center For Research Resources2005–2006
  • Depression In Alzheimer'S Disease (DAD)National Center For Research Resources2005–2006
  • FMRI In Pre-Symptomatic Ps1-Related Alzheimer'S DiseaseNational Institute On Aging2003–2005
  • FMRI In Pre-Symptomatic Ps1-Related Alzheimer'S DiseaseNational Institute On Aging2003

Hospital Affiliations